Analyst Price Target is $203.00
▲ +0.00% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for ShockWave Medical in the last 3 months. The average price target is $203.00, with a high forecast of $220.00 and a low forecast of $189.00. The average price target represents a 0.00% upside from the last price of $202.99.
Current Consensus is
The current consensus among 7 contributing investment analysts is to hold stock in ShockWave Medical. This Hold consensus rating has held steady for over two years.
Shockwave Medical, Inc. operates as a medical device company, which focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton on June 17, 2009 and is headquartered in Santa Clara, CA.